Medical Care
Global Tumor-Infiltrating Lymphocyte Therapy Market Research Report 2025
- Jan 17, 26
- ID: 677726
- Pages: 86
- Figures: 90
- Views: 17
This report aims to provide a comprehensive presentation of the global market for Tumor-Infiltrating Lymphocyte Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor-Infiltrating Lymphocyte Therapy.
The Tumor-Infiltrating Lymphocyte Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor-Infiltrating Lymphocyte Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor-Infiltrating Lymphocyte Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Iovance Biotherapeutics
Moffitt Cancer Center
Essen Biotech
Turnstone Biologics
Obsidian Therapeutics
Hervor Therapeutics
Intima Bioscience
Instil Bio
Shanghai Juncell Therapeutics
Suzhou BlueHorse Therapeutics
Grit Biotechnology
TCRCure Biopharma
BioSyngen
Sino-Cell Biomed
Segment by Type
Combined with IL-2
Not Combined with IL-2
Segment by Application
Melanoma
Cervical Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor-Infiltrating Lymphocyte Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Tumor-Infiltrating Lymphocyte Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor-Infiltrating Lymphocyte Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor-Infiltrating Lymphocyte Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Iovance Biotherapeutics
Moffitt Cancer Center
Essen Biotech
Turnstone Biologics
Obsidian Therapeutics
Hervor Therapeutics
Intima Bioscience
Instil Bio
Shanghai Juncell Therapeutics
Suzhou BlueHorse Therapeutics
Grit Biotechnology
TCRCure Biopharma
BioSyngen
Sino-Cell Biomed
Segment by Type
Combined with IL-2
Not Combined with IL-2
Segment by Application
Melanoma
Cervical Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor-Infiltrating Lymphocyte Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Combined with IL-2
1.2.3 Not Combined with IL-2
1.3 Market by Application
1.3.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Melanoma
1.3.3 Cervical Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Perspective (2020-2031)
2.2 Global Tumor-Infiltrating Lymphocyte Therapy Growth Trends by Region
2.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Region (2020-2025)
2.2.3 Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (2026-2031)
2.3 Tumor-Infiltrating Lymphocyte Therapy Market Dynamics
2.3.1 Tumor-Infiltrating Lymphocyte Therapy Industry Trends
2.3.2 Tumor-Infiltrating Lymphocyte Therapy Market Drivers
2.3.3 Tumor-Infiltrating Lymphocyte Therapy Market Challenges
2.3.4 Tumor-Infiltrating Lymphocyte Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue
3.1.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue (2020-2025)
3.1.2 Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor-Infiltrating Lymphocyte Therapy Revenue
3.4 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio
3.4.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2024
3.5 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy Head office and Area Served
3.6 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Product and Application
3.7 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Type
4.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Type (2020-2025)
4.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (2026-2031)
5 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Application
5.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Application (2020-2025)
5.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
6.2 North America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
6.4 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
7.2 Europe Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
7.4 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
8.2 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
9.2 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
9.4 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
10.2 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Iovance Biotherapeutics
11.1.1 Iovance Biotherapeutics Company Details
11.1.2 Iovance Biotherapeutics Business Overview
11.1.3 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.1.4 Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.1.5 Iovance Biotherapeutics Recent Development
11.2 Moffitt Cancer Center
11.2.1 Moffitt Cancer Center Company Details
11.2.2 Moffitt Cancer Center Business Overview
11.2.3 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Introduction
11.2.4 Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.2.5 Moffitt Cancer Center Recent Development
11.3 Essen Biotech
11.3.1 Essen Biotech Company Details
11.3.2 Essen Biotech Business Overview
11.3.3 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Introduction
11.3.4 Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.3.5 Essen Biotech Recent Development
11.4 Turnstone Biologics
11.4.1 Turnstone Biologics Company Details
11.4.2 Turnstone Biologics Business Overview
11.4.3 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.4.4 Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.4.5 Turnstone Biologics Recent Development
11.5 Obsidian Therapeutics
11.5.1 Obsidian Therapeutics Company Details
11.5.2 Obsidian Therapeutics Business Overview
11.5.3 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.5.4 Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.5.5 Obsidian Therapeutics Recent Development
11.6 Hervor Therapeutics
11.6.1 Hervor Therapeutics Company Details
11.6.2 Hervor Therapeutics Business Overview
11.6.3 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.6.4 Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.6.5 Hervor Therapeutics Recent Development
11.7 Intima Bioscience
11.7.1 Intima Bioscience Company Details
11.7.2 Intima Bioscience Business Overview
11.7.3 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Introduction
11.7.4 Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.7.5 Intima Bioscience Recent Development
11.8 Instil Bio
11.8.1 Instil Bio Company Details
11.8.2 Instil Bio Business Overview
11.8.3 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Introduction
11.8.4 Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.8.5 Instil Bio Recent Development
11.9 Shanghai Juncell Therapeutics
11.9.1 Shanghai Juncell Therapeutics Company Details
11.9.2 Shanghai Juncell Therapeutics Business Overview
11.9.3 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.9.4 Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.9.5 Shanghai Juncell Therapeutics Recent Development
11.10 Suzhou BlueHorse Therapeutics
11.10.1 Suzhou BlueHorse Therapeutics Company Details
11.10.2 Suzhou BlueHorse Therapeutics Business Overview
11.10.3 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.10.4 Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.10.5 Suzhou BlueHorse Therapeutics Recent Development
11.11 Grit Biotechnology
11.11.1 Grit Biotechnology Company Details
11.11.2 Grit Biotechnology Business Overview
11.11.3 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Introduction
11.11.4 Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.11.5 Grit Biotechnology Recent Development
11.12 TCRCure Biopharma
11.12.1 TCRCure Biopharma Company Details
11.12.2 TCRCure Biopharma Business Overview
11.12.3 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Introduction
11.12.4 TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.12.5 TCRCure Biopharma Recent Development
11.13 BioSyngen
11.13.1 BioSyngen Company Details
11.13.2 BioSyngen Business Overview
11.13.3 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Introduction
11.13.4 BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.13.5 BioSyngen Recent Development
11.14 Sino-Cell Biomed
11.14.1 Sino-Cell Biomed Company Details
11.14.2 Sino-Cell Biomed Business Overview
11.14.3 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Introduction
11.14.4 Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.14.5 Sino-Cell Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Combined with IL-2
1.2.3 Not Combined with IL-2
1.3 Market by Application
1.3.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Melanoma
1.3.3 Cervical Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Perspective (2020-2031)
2.2 Global Tumor-Infiltrating Lymphocyte Therapy Growth Trends by Region
2.2.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Region (2020-2025)
2.2.3 Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (2026-2031)
2.3 Tumor-Infiltrating Lymphocyte Therapy Market Dynamics
2.3.1 Tumor-Infiltrating Lymphocyte Therapy Industry Trends
2.3.2 Tumor-Infiltrating Lymphocyte Therapy Market Drivers
2.3.3 Tumor-Infiltrating Lymphocyte Therapy Market Challenges
2.3.4 Tumor-Infiltrating Lymphocyte Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue
3.1.1 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Revenue (2020-2025)
3.1.2 Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor-Infiltrating Lymphocyte Therapy Revenue
3.4 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio
3.4.1 Global Tumor-Infiltrating Lymphocyte Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2024
3.5 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy Head office and Area Served
3.6 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Product and Application
3.7 Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Type
4.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Type (2020-2025)
4.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (2026-2031)
5 Tumor-Infiltrating Lymphocyte Therapy Breakdown Data by Application
5.1 Global Tumor-Infiltrating Lymphocyte Therapy Historic Market Size by Application (2020-2025)
5.2 Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
6.2 North America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
6.4 North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
7.2 Europe Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
7.4 Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
8.2 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
9.2 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
9.4 Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size (2020-2031)
10.2 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Iovance Biotherapeutics
11.1.1 Iovance Biotherapeutics Company Details
11.1.2 Iovance Biotherapeutics Business Overview
11.1.3 Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.1.4 Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.1.5 Iovance Biotherapeutics Recent Development
11.2 Moffitt Cancer Center
11.2.1 Moffitt Cancer Center Company Details
11.2.2 Moffitt Cancer Center Business Overview
11.2.3 Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Introduction
11.2.4 Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.2.5 Moffitt Cancer Center Recent Development
11.3 Essen Biotech
11.3.1 Essen Biotech Company Details
11.3.2 Essen Biotech Business Overview
11.3.3 Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Introduction
11.3.4 Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.3.5 Essen Biotech Recent Development
11.4 Turnstone Biologics
11.4.1 Turnstone Biologics Company Details
11.4.2 Turnstone Biologics Business Overview
11.4.3 Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.4.4 Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.4.5 Turnstone Biologics Recent Development
11.5 Obsidian Therapeutics
11.5.1 Obsidian Therapeutics Company Details
11.5.2 Obsidian Therapeutics Business Overview
11.5.3 Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.5.4 Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.5.5 Obsidian Therapeutics Recent Development
11.6 Hervor Therapeutics
11.6.1 Hervor Therapeutics Company Details
11.6.2 Hervor Therapeutics Business Overview
11.6.3 Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.6.4 Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.6.5 Hervor Therapeutics Recent Development
11.7 Intima Bioscience
11.7.1 Intima Bioscience Company Details
11.7.2 Intima Bioscience Business Overview
11.7.3 Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Introduction
11.7.4 Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.7.5 Intima Bioscience Recent Development
11.8 Instil Bio
11.8.1 Instil Bio Company Details
11.8.2 Instil Bio Business Overview
11.8.3 Instil Bio Tumor-Infiltrating Lymphocyte Therapy Introduction
11.8.4 Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.8.5 Instil Bio Recent Development
11.9 Shanghai Juncell Therapeutics
11.9.1 Shanghai Juncell Therapeutics Company Details
11.9.2 Shanghai Juncell Therapeutics Business Overview
11.9.3 Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.9.4 Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.9.5 Shanghai Juncell Therapeutics Recent Development
11.10 Suzhou BlueHorse Therapeutics
11.10.1 Suzhou BlueHorse Therapeutics Company Details
11.10.2 Suzhou BlueHorse Therapeutics Business Overview
11.10.3 Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Introduction
11.10.4 Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.10.5 Suzhou BlueHorse Therapeutics Recent Development
11.11 Grit Biotechnology
11.11.1 Grit Biotechnology Company Details
11.11.2 Grit Biotechnology Business Overview
11.11.3 Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Introduction
11.11.4 Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.11.5 Grit Biotechnology Recent Development
11.12 TCRCure Biopharma
11.12.1 TCRCure Biopharma Company Details
11.12.2 TCRCure Biopharma Business Overview
11.12.3 TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Introduction
11.12.4 TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.12.5 TCRCure Biopharma Recent Development
11.13 BioSyngen
11.13.1 BioSyngen Company Details
11.13.2 BioSyngen Business Overview
11.13.3 BioSyngen Tumor-Infiltrating Lymphocyte Therapy Introduction
11.13.4 BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.13.5 BioSyngen Recent Development
11.14 Sino-Cell Biomed
11.14.1 Sino-Cell Biomed Company Details
11.14.2 Sino-Cell Biomed Business Overview
11.14.3 Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Introduction
11.14.4 Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
11.14.5 Sino-Cell Biomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Combined with IL-2
Table 3. Key Players of Not Combined with IL-2
Table 4. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2020-2025)
Table 8. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2026-2031)
Table 10. Tumor-Infiltrating Lymphocyte Therapy Market Trends
Table 11. Tumor-Infiltrating Lymphocyte Therapy Market Drivers
Table 12. Tumor-Infiltrating Lymphocyte Therapy Market Challenges
Table 13. Tumor-Infiltrating Lymphocyte Therapy Market Restraints
Table 14. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players (2020-2025)
Table 16. Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-Infiltrating Lymphocyte Therapy as of 2024)
Table 17. Ranking of Global Top Tumor-Infiltrating Lymphocyte Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Headquarters and Area Served
Table 20. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Product and Application
Table 21. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Iovance Biotherapeutics Company Details
Table 47. Iovance Biotherapeutics Business Overview
Table 48. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 49. Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 50. Iovance Biotherapeutics Recent Development
Table 51. Moffitt Cancer Center Company Details
Table 52. Moffitt Cancer Center Business Overview
Table 53. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product
Table 54. Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 55. Moffitt Cancer Center Recent Development
Table 56. Essen Biotech Company Details
Table 57. Essen Biotech Business Overview
Table 58. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product
Table 59. Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 60. Essen Biotech Recent Development
Table 61. Turnstone Biologics Company Details
Table 62. Turnstone Biologics Business Overview
Table 63. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product
Table 64. Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 65. Turnstone Biologics Recent Development
Table 66. Obsidian Therapeutics Company Details
Table 67. Obsidian Therapeutics Business Overview
Table 68. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 69. Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 70. Obsidian Therapeutics Recent Development
Table 71. Hervor Therapeutics Company Details
Table 72. Hervor Therapeutics Business Overview
Table 73. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 74. Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 75. Hervor Therapeutics Recent Development
Table 76. Intima Bioscience Company Details
Table 77. Intima Bioscience Business Overview
Table 78. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product
Table 79. Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 80. Intima Bioscience Recent Development
Table 81. Instil Bio Company Details
Table 82. Instil Bio Business Overview
Table 83. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product
Table 84. Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 85. Instil Bio Recent Development
Table 86. Shanghai Juncell Therapeutics Company Details
Table 87. Shanghai Juncell Therapeutics Business Overview
Table 88. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 89. Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 90. Shanghai Juncell Therapeutics Recent Development
Table 91. Suzhou BlueHorse Therapeutics Company Details
Table 92. Suzhou BlueHorse Therapeutics Business Overview
Table 93. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 94. Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 95. Suzhou BlueHorse Therapeutics Recent Development
Table 96. Grit Biotechnology Company Details
Table 97. Grit Biotechnology Business Overview
Table 98. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product
Table 99. Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 100. Grit Biotechnology Recent Development
Table 101. TCRCure Biopharma Company Details
Table 102. TCRCure Biopharma Business Overview
Table 103. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product
Table 104. TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 105. TCRCure Biopharma Recent Development
Table 106. BioSyngen Company Details
Table 107. BioSyngen Business Overview
Table 108. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product
Table 109. BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 110. BioSyngen Recent Development
Table 111. Sino-Cell Biomed Company Details
Table 112. Sino-Cell Biomed Business Overview
Table 113. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product
Table 114. Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 115. Sino-Cell Biomed Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Tumor-Infiltrating Lymphocyte Therapy Picture
Figure 2. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Type: 2024 VS 2031
Figure 4. Combined with IL-2 Features
Figure 5. Not Combined with IL-2 Features
Figure 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Application: 2024 VS 2031
Figure 8. Melanoma Case Studies
Figure 9. Cervical Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Tumor-Infiltrating Lymphocyte Therapy Report Years Considered
Figure 12. Global Tumor-Infiltrating Lymphocyte Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Tumor-Infiltrating Lymphocyte Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players in 2024
Figure 16. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2024
Figure 18. North America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 20. United States Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 24. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2020-2031)
Figure 32. China Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Iovance Biotherapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 48. Moffitt Cancer Center Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 49. Essen Biotech Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 50. Turnstone Biologics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 51. Obsidian Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 52. Hervor Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 53. Intima Bioscience Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 54. Instil Bio Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 55. Shanghai Juncell Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 56. Suzhou BlueHorse Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 57. Grit Biotechnology Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 58. TCRCure Biopharma Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 59. BioSyngen Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 60. Sino-Cell Biomed Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Combined with IL-2
Table 3. Key Players of Not Combined with IL-2
Table 4. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2020-2025)
Table 8. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2026-2031)
Table 10. Tumor-Infiltrating Lymphocyte Therapy Market Trends
Table 11. Tumor-Infiltrating Lymphocyte Therapy Market Drivers
Table 12. Tumor-Infiltrating Lymphocyte Therapy Market Challenges
Table 13. Tumor-Infiltrating Lymphocyte Therapy Market Restraints
Table 14. Global Tumor-Infiltrating Lymphocyte Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players (2020-2025)
Table 16. Global Top Tumor-Infiltrating Lymphocyte Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-Infiltrating Lymphocyte Therapy as of 2024)
Table 17. Ranking of Global Top Tumor-Infiltrating Lymphocyte Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Headquarters and Area Served
Table 20. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Product and Application
Table 21. Global Key Players of Tumor-Infiltrating Lymphocyte Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Tumor-Infiltrating Lymphocyte Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Tumor-Infiltrating Lymphocyte Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Iovance Biotherapeutics Company Details
Table 47. Iovance Biotherapeutics Business Overview
Table 48. Iovance Biotherapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 49. Iovance Biotherapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 50. Iovance Biotherapeutics Recent Development
Table 51. Moffitt Cancer Center Company Details
Table 52. Moffitt Cancer Center Business Overview
Table 53. Moffitt Cancer Center Tumor-Infiltrating Lymphocyte Therapy Product
Table 54. Moffitt Cancer Center Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 55. Moffitt Cancer Center Recent Development
Table 56. Essen Biotech Company Details
Table 57. Essen Biotech Business Overview
Table 58. Essen Biotech Tumor-Infiltrating Lymphocyte Therapy Product
Table 59. Essen Biotech Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 60. Essen Biotech Recent Development
Table 61. Turnstone Biologics Company Details
Table 62. Turnstone Biologics Business Overview
Table 63. Turnstone Biologics Tumor-Infiltrating Lymphocyte Therapy Product
Table 64. Turnstone Biologics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 65. Turnstone Biologics Recent Development
Table 66. Obsidian Therapeutics Company Details
Table 67. Obsidian Therapeutics Business Overview
Table 68. Obsidian Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 69. Obsidian Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 70. Obsidian Therapeutics Recent Development
Table 71. Hervor Therapeutics Company Details
Table 72. Hervor Therapeutics Business Overview
Table 73. Hervor Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 74. Hervor Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 75. Hervor Therapeutics Recent Development
Table 76. Intima Bioscience Company Details
Table 77. Intima Bioscience Business Overview
Table 78. Intima Bioscience Tumor-Infiltrating Lymphocyte Therapy Product
Table 79. Intima Bioscience Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 80. Intima Bioscience Recent Development
Table 81. Instil Bio Company Details
Table 82. Instil Bio Business Overview
Table 83. Instil Bio Tumor-Infiltrating Lymphocyte Therapy Product
Table 84. Instil Bio Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 85. Instil Bio Recent Development
Table 86. Shanghai Juncell Therapeutics Company Details
Table 87. Shanghai Juncell Therapeutics Business Overview
Table 88. Shanghai Juncell Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 89. Shanghai Juncell Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 90. Shanghai Juncell Therapeutics Recent Development
Table 91. Suzhou BlueHorse Therapeutics Company Details
Table 92. Suzhou BlueHorse Therapeutics Business Overview
Table 93. Suzhou BlueHorse Therapeutics Tumor-Infiltrating Lymphocyte Therapy Product
Table 94. Suzhou BlueHorse Therapeutics Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 95. Suzhou BlueHorse Therapeutics Recent Development
Table 96. Grit Biotechnology Company Details
Table 97. Grit Biotechnology Business Overview
Table 98. Grit Biotechnology Tumor-Infiltrating Lymphocyte Therapy Product
Table 99. Grit Biotechnology Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 100. Grit Biotechnology Recent Development
Table 101. TCRCure Biopharma Company Details
Table 102. TCRCure Biopharma Business Overview
Table 103. TCRCure Biopharma Tumor-Infiltrating Lymphocyte Therapy Product
Table 104. TCRCure Biopharma Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 105. TCRCure Biopharma Recent Development
Table 106. BioSyngen Company Details
Table 107. BioSyngen Business Overview
Table 108. BioSyngen Tumor-Infiltrating Lymphocyte Therapy Product
Table 109. BioSyngen Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 110. BioSyngen Recent Development
Table 111. Sino-Cell Biomed Company Details
Table 112. Sino-Cell Biomed Business Overview
Table 113. Sino-Cell Biomed Tumor-Infiltrating Lymphocyte Therapy Product
Table 114. Sino-Cell Biomed Revenue in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025) & (US$ Million)
Table 115. Sino-Cell Biomed Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Tumor-Infiltrating Lymphocyte Therapy Picture
Figure 2. Global Tumor-Infiltrating Lymphocyte Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Type: 2024 VS 2031
Figure 4. Combined with IL-2 Features
Figure 5. Not Combined with IL-2 Features
Figure 6. Global Tumor-Infiltrating Lymphocyte Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Application: 2024 VS 2031
Figure 8. Melanoma Case Studies
Figure 9. Cervical Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Tumor-Infiltrating Lymphocyte Therapy Report Years Considered
Figure 12. Global Tumor-Infiltrating Lymphocyte Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Tumor-Infiltrating Lymphocyte Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Players in 2024
Figure 16. Global Tumor-Infiltrating Lymphocyte Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Tumor-Infiltrating Lymphocyte Therapy Revenue in 2024
Figure 18. North America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 20. United States Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 24. Germany Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Tumor-Infiltrating Lymphocyte Therapy Market Share by Region (2020-2031)
Figure 32. China Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Tumor-Infiltrating Lymphocyte Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Tumor-Infiltrating Lymphocyte Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Iovance Biotherapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 48. Moffitt Cancer Center Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 49. Essen Biotech Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 50. Turnstone Biologics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 51. Obsidian Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 52. Hervor Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 53. Intima Bioscience Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 54. Instil Bio Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 55. Shanghai Juncell Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 56. Suzhou BlueHorse Therapeutics Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 57. Grit Biotechnology Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 58. TCRCure Biopharma Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 59. BioSyngen Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 60. Sino-Cell Biomed Revenue Growth Rate in Tumor-Infiltrating Lymphocyte Therapy Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232